ArticleCancer science2020

In vitro and in vivo synergistic efficacy of ceritinib combined with programmed cell death ligand-1 inhibitor in anaplastic lymphoma kinase-rearranged non-small-cell lung cancer.

Ping Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.